Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000930413-06-005004
Filing Date
2006-06-29
Accepted
2006-06-29 14:51:54
Documents
5
Period of Report
2006-03-31

Document Format Files

Seq Description Document Type Size
1 c43317_10k.txt 10-K 294346
2 c43317_ex31-1.txt EX-31.1 4159
3 c43317_ex31-2.txt EX-31.2 3775
4 c43317_ex32-1.txt EX-32.1 1847
5 c43317_ex32-2.txt EX-32.2 1875
  Complete submission text file 0000930413-06-005004.txt   307431
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /DE/ (Filer) CIK: 0001053369 (see all company filings)

EIN.: 223542636 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-15697 | Film No.: 06933295
SIC: 2834 Pharmaceutical Preparations